273 related articles for article (PubMed ID: 24934811)
1. ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.
Wilson BJ; Saab KR; Ma J; Schatton T; Pütz P; Zhan Q; Murphy GF; Gasser M; Waaga-Gasser AM; Frank NY; Frank MH
Cancer Res; 2014 Aug; 74(15):4196-207. PubMed ID: 24934811
[TBL] [Abstract][Full Text] [Related]
2. Identification of cells initiating human melanomas.
Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
[TBL] [Abstract][Full Text] [Related]
3. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
4. Modulation of T-cell activation by malignant melanoma initiating cells.
Schatton T; Schütte U; Frank NY; Zhan Q; Hoerning A; Robles SC; Zhou J; Hodi FS; Spagnoli GC; Murphy GF; Frank MH
Cancer Res; 2010 Jan; 70(2):697-708. PubMed ID: 20068175
[TBL] [Abstract][Full Text] [Related]
5. Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
Lutz NW; Banerjee P; Wilson BJ; Ma J; Cozzone PJ; Frank MH
PLoS One; 2016; 11(8):e0161803. PubMed ID: 27560924
[TBL] [Abstract][Full Text] [Related]
6. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
[TBL] [Abstract][Full Text] [Related]
7. Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk.
Lin JY; Zhang M; Schatton T; Wilson BJ; Alloo A; Ma J; Qureshi AA; Frank NY; Han J; Frank MH
Biochem Biophys Res Commun; 2013 Jul; 436(3):536-42. PubMed ID: 23770371
[TBL] [Abstract][Full Text] [Related]
8. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.
Linley AJ; Mathieu MG; Miles AK; Rees RC; McArdle SE; Regad T
J Biol Chem; 2012 Apr; 287(17):13633-43. PubMed ID: 22393060
[TBL] [Abstract][Full Text] [Related]
9. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
Lai CY; Schwartz BE; Hsu MY
Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
[TBL] [Abstract][Full Text] [Related]
10. ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer.
Guo Q; Grimmig T; Gonzalez G; Giobbie-Hurder A; Berg G; Carr N; Wilson BJ; Banerjee P; Ma J; Gold JS; Nandi B; Huang Q; Waaga-Gasser AM; Lian CG; Murphy GF; Frank MH; Gasser M; Frank NY
J Biol Chem; 2018 Jul; 293(28):11166-11178. PubMed ID: 29789423
[TBL] [Abstract][Full Text] [Related]
11. Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
Czyz M; Koprowska K; Sztiller-Sikorska M
Cancer Biol Ther; 2013 Feb; 14(2):135-45. PubMed ID: 23192276
[TBL] [Abstract][Full Text] [Related]
12. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.
Keniya MV; Holmes AR; Niimi M; Lamping E; Gillet JP; Gottesman MM; Cannon RD
Mol Pharm; 2014 Oct; 11(10):3452-62. PubMed ID: 25115303
[TBL] [Abstract][Full Text] [Related]
14. CD271 is an imperfect marker for melanoma initiating cells.
Cheli Y; Bonnazi VF; Jacquel A; Allegra M; De Donatis GM; Bahadoran P; Bertolotto C; Ballotti R
Oncotarget; 2014 Jul; 5(14):5272-83. PubMed ID: 25105565
[TBL] [Abstract][Full Text] [Related]
15. Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.
Milosevic V; Kopecka J; Salaroglio IC; Libener R; Napoli F; Izzo S; Orecchia S; Ananthanarayanan P; Bironzo P; Grosso F; Tabbò F; Comunanza V; Alexa-Stratulat T; Bussolino F; Righi L; Novello S; Scagliotti GV; Riganti C
Int J Cancer; 2020 Jan; 146(1):192-207. PubMed ID: 31107974
[TBL] [Abstract][Full Text] [Related]
16. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.
Cheung PF; Cheng CK; Wong NC; Ho JC; Yip CW; Lui VC; Cheung AN; Fan ST; Cheung ST
PLoS One; 2011; 6(12):e28246. PubMed ID: 22194816
[TBL] [Abstract][Full Text] [Related]
17. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
Wouters J; Stas M; Gremeaux L; Govaere O; Van den Broeck A; Maes H; Agostinis P; Roskams T; van den Oord JJ; Vankelecom H
PLoS One; 2013; 8(10):e76550. PubMed ID: 24098529
[TBL] [Abstract][Full Text] [Related]
18. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
Chartrain M; Riond J; Stennevin A; Vandenberghe I; Gomes B; Lamant L; Meyer N; Gairin JE; Guilbaud N; Annereau JP
PLoS One; 2012; 7(5):e36762. PubMed ID: 22675422
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
Xiao J; Egger ME; McMasters KM; Hao H
BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the roles of ABCB5 in normal and cancer cells.
Duvivier L; Gillet JP
Trends Cancer; 2022 Oct; 8(10):795-798. PubMed ID: 35907754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
